Device Trial Radar · NCT05415384
Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Aug 1, 2022
Primary completion
May 2027
Study completion May 2027
Sponsor
- Lead sponsor
- Wake Forest University Health SciencesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 13, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of Surgical Stabilization of Rib Fractures (SSRF) without cryoablation
Conditions
- Pain, Postoperative
- Rib Fracture Multiple
Interventions
Cryoablation of Intercostal NervesDevice
Using Atricure device, cryoice, intercostal nerves 3-8 will be ablated in the experimental arm. This is in addition to mechanical fixation of rib fractures and multimodal systemic therapy.
Standard surgical treatment of patients with multiple rib fracturesProcedure
Standard surgical treatment of patients with multiple rib fractures
Primary outcomes
What the sponsor says the trial is designed to measure.
- Morphine Milligram Equivalents Use following InterventionTime frame: Baseline
3 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Wake Forest University Health Sciences
Winston-Salem, North Carolina · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.